30PUpdate on the phase II SUMMIT trial: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer

Authors

Keywords

Journal

Volume 30, Issue Supplement_3, Pages -

Publisher

Oxford University Press (OUP)

Online

2019-05-13

DOI

10.1093/annonc/mdz095.029

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started